Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer.

Journal:

Journal of Clinical Oncology

Published:

2026-01-14

DOI:

10.1200/jco-25-01828

Affiliations:

28

Authors:

28

Go to article

Institutions	Authors	Share
Queen's University, Canada	2.000000	0.07
Hiroshima University (HU), Japan	1.000000	0.04
IRCCS National Cancer Institute (INT) Bari, Italy	1.000000	0.04
Bellvitge Biomedical Research Institute (IDIBELL), Spain	1.000000	0.04
Seoul St. Mary's Hospital, South Korea	1.000000	0.04
Guangdong Academy of Medical Sciences (Guangdong Provincial People’s Hospital), China	1.000000	0.04
Medical University of Gdańsk (MUG), Poland	1.000000	0.04
Dalhousie University, Canada	1.000000	0.04
St Vincent's Hospital Melbourne, Australia	1.000000	0.04
Alps Grenoble University Hospital (CHU Grenoble Alpes), France	1.000000	0.04
Kindai University Hospital, Japan	1.000000	0.04
Wakayama Medical University, Japan	1.000000	0.04
West Japan Oncology Group (WJOG), Japan	1.000000	0.04
Erasmus MC Cancer Institute, Netherlands	1.000000	0.04
Kindai University, Japan	1.000000	0.04
IRCCS Istituto Nazionale Tumori IRCCS-Fondazione G. Pascale, Italy	1.000000	0.04
The Ottawa Hospital (TOH), Canada	1.000000	0.04
Princess Margaret Cancer Centre, U of T, Canada	1.000000	0.04
Hôpital Sainte Musse, CH Toulon, France	1.000000	0.04
CHRU de Besançon, France	1.000000	0.04
The University of Sydney (USYD), Australia	1.000000	0.04
Hôpital du Sacré-Cœur de Montréal, Canada	1.000000	0.04
Cancer Research Center of Marseille (CRCM), France	1.000000	0.04
Centre Hospitalier du Mans, France	1.000000	0.04
Hospital Universitario Fundación Jiménez Díaz (FJD), UAM, Spain	1.000000	0.04
French Cooperative Thoracic Group (IFCT), France	1.000000	0.04
Hospital General Universitario de Alicante (HGUA), Spain	0.500000	0.02
University of Alicante (UA), Spain	0.500000	0.02

Interested in Oncology and Carcinogenesis?